Literature DB >> 20819396

Modified skin-window technique in cynomolgus macaques (Macaca fasicularis) for assessing neutrophil extravasation.

Sean Maguire1, Eric Dobrzynski, R Katherine Alpaugh.   

Abstract

Alterations in neutrophil extravasation are seen in disease states and in response to therapeutics. To investigate neutrophil extravasation during the acute inflammatory response, a skin-window technique used in humans was adapted for use in cynomolgus macaques (Macaca fasicularis). Modulation of neutrophil extravasation was attempted with systemic methotrexate and local application of the anaphylatoxin recombinant C5a (rC5a). On day 1, skin windows were created in 4 ketamine-anesthetized monkeys on both forearms by mildly abrading the skin and then overlaying the abrasions with filter paper either saturated in saline or rC5a for 6 h. At 2.5 h prior to generation of new skin windows on day 2, the monkeys received 4.5 mg methotrexate IM, and skin windows and treatment with saline or rC5a were repeated on new forearm sites on each monkey. All papers were analyzed for albumin, neutrophil number, and the neutrophil chemoattractant IL8. Day 1 albumin levels did not differ between groups, indicating consistent abrasion. Methotrexate given prior to the day 2 abrasions reduced neutrophil extravasation and IL8 levels compared with those on day 1. rC5a partially abrogated the methotrexate-induced reduction in neutrophil extravasation and IL8 production. The skin-window technique was well tolerated by the monkeys and successfully accommodated measurement of changes in neutrophil extravasation in response to inflammatory modulators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819396      PMCID: PMC2919190     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  30 in total

1.  Leukocyte migration in vivo: a new method of study.

Authors:  M F Mass; P B Dean; W L Weston; J R Humbert
Journal:  J Lab Clin Med       Date:  1975-12

2.  Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients.

Authors:  J W O'Callaghan; M J Forrest; P M Brooks
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 3.  Therapeutic progress--review XXXVII. Methotrexate--an immunomodulator with expanding indications.

Authors:  R C Horton
Journal:  J Clin Pharm Ther       Date:  1990-04       Impact factor: 2.512

4.  Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a.

Authors:  C R Suarez; W C Pickett; D H Bell; D K McClintock; A L Oronsky; S S Kerwar
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

5.  Skin window chambers, a novel method for recovering the cells involved in delayed-type hypersensitivity.

Authors:  M J MacPhee; H Rode; M Broadhead; N V Christou; J L Meakins; J Gordon
Journal:  J Immunol Methods       Date:  1987-11-05       Impact factor: 2.303

6.  Methotrexate in rheumatoid arthritis.

Authors:  D E Furst; J M Kremer
Journal:  Arthritis Rheum       Date:  1988-03

7.  Studies of human C5a as a mediator of inflammation in normal human skin.

Authors:  K B Yancey; C H Hammer; L Harvath; L Renfer; M M Frank; T J Lawley
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.

Authors:  T Ternowitz; P Bjerring; P H Andersen; J M Schröder; K Kragballe
Journal:  J Invest Dermatol       Date:  1987-08       Impact factor: 8.551

9.  Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients.

Authors:  T Ternowitz; T Herlin
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1985

10.  Humoral inhibition of neutrophil chemotaxis in Crohn's disease.

Authors:  R D'Amelio; F Pallone; S Le Moli; O Pontesilli; R Ricci; S Montano; P Rossi
Journal:  Scand J Immunol       Date:  1985-12       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.